Bristol Myers Squibb aims to make its Hyderabad facility largest unit outside US by 2025


Our Bureau

New York, NY

US drugmaker Bristol Myers Squibb is aiming to expand its R&D presence in India. It expects its newly inaugurated Hyderabad facility to become its largest unit outside the US by 2025. The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world’s largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

The $100-million facility was inaugurated by Christopher Boerner, CEO. expected to employ over 1,500 employees and will be used to enhance its drug development through the use of digital technologies and AI, he said in his keynote speech at the BioAsia conference.

The company is also developing next-generation cell therapies for autoimmune diseases such as multiple sclerosis and plans to use AI technologies to accelerate the development, Boerner said, adding that it plans to make these more widely available, including in markets such as India.

Bristol Myers operates a research and development centre in Bengaluru in partnership with the Biocon Group’s Syngene International.

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top